“…There were no reported complications from ibuprofen. Several anesthetic agents and cough medicines containing opioids have been associated with mast cell degranulation, with the potential for cardiovascular shock, bronchospasm, and death in patients with cutaneous mastocytosis . Consistent with a prior report of dextromethorphan cough suppressant causing cutaneous flare, two (6%) subjects had erythema and pruritus with non‐opioid‐containing cough medications .…”
Severe complications are not common with historically identified triggers. Disease does not resolve before adolescence in most children. UP has a minimal effect on quality of life for most children.
“…There were no reported complications from ibuprofen. Several anesthetic agents and cough medicines containing opioids have been associated with mast cell degranulation, with the potential for cardiovascular shock, bronchospasm, and death in patients with cutaneous mastocytosis . Consistent with a prior report of dextromethorphan cough suppressant causing cutaneous flare, two (6%) subjects had erythema and pruritus with non‐opioid‐containing cough medications .…”
Severe complications are not common with historically identified triggers. Disease does not resolve before adolescence in most children. UP has a minimal effect on quality of life for most children.
“…The authors gave subcutaneous injections of codeine to five patients of whom three were children. In three of five subjects systemic symptoms were reported in response to codeine, in three of five challenges systemic symptoms were reported to polymyxin B. Subcutaneous codeine induced flushing and an increase in urinary histamine excretion (31).…”
Section: Mast Cell Activation By Drugs Used In the Perioperative Periodmentioning
confidence: 99%
“…Induction or promotion of mediator release has been ascribed to trigger factors, conventional advice suggests that these triggers should be avoided e.g. emotional or environmental stress, aspirin, morphine and its derivatives, tubocurare type muscle relaxants, alcohol, antibiotics and radiocontrast media (31). It is acknowledged that there is little data on which to base these recommendations (32) with some experience suggesting that drugs commonly believed to be contra-indicated are a problem in <10% of patients (3).…”
Section: Mast Cell Activation By Drugs Used In the Perioperative Periodmentioning
The risks for most pediatric patients are overstated by mastocytosis websites. Most pediatric patients with CM do not appear to be at risk of widespread mast cell degranulation during anesthesia but because of the small number of cases reported, the risk cannot be ascertained with confidence. Children with SM and a high baseline serum tryptase (marker of mast cell burden) may merit extra precautions but experience in this subgroup is even more limited. Drugs which cause minimal histamine release can be selected from the range of drugs available in most pediatric centers without compromise to technique.
“…50 Patients with mastocytosis may also be more sensitive to venoms of stinging insects. There are a number of activators of mast cell secretion, which work through immunological and nonimmunological mechanisms, which are summarised in table 4.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.